Cell line development is a critical determinant of success in biologics manufacturing. It lays the foundation for product yield, quality and long-term process st...

Flexibility is an operational imperative in today’s fast-evolving biopharmaceutical industry. Contract development and manufacturing organisations (CDMOs), as in...

Part 3: Pilot and Manufacturing Scale Comparison of DynaDrive S.U.B. Capabilities Introduction Commercialisation of a drug is a monumental milestone that h...

As biopharma therapies become more sensitive, costly and complex, traditional compliance frameworks are no longer enough. Real-time visibility and IoT innovation...

Cell & Gene Therapy (CGT) products face a unique challenge in the required pyrogen testing for injectable wares. Since this test was written for conventional...

The aProximateTM Proximal Tubule Cell (PTC) model offers a cutting-edge platform for the evaluation of drug-induced nephrotoxicity, radioconjugate retention and ...